Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Eevia Health receives multiple sales orders for c. KSEK 1 000 (KEUR 92)

Eevia Health PLC ("Eevia" or "The Company") received several sales orders for extracts totaling KEUR 92 from various European, Australian, and American customers.[1]Several customers placed a total of KEUR 90 in sales orders. Three orders came from one distributor, NutriOriginal (New Jersey, US): KEUR 18 for Feno-Chaga Organic, a mushroom extract; KEUR 11 for Feno-Myrtillus 25 Organic (Bilberry Extract); and KEUR 15 for Feno-Chaga NFS Organic. Another sales order is from the Australian distributor Ingredients Plus for Feno-Sambucus 17 (Elderberry Extract), KEUR 18. The end customer is an

BlueNord: Share Capital Increase Registered Following Issue of New Shares - Option Exercise

Oslo, 28 August 2024: Reference is made to the stock exchange announcement on 22 August 2024 by BlueNord ASA ("BlueNord" or the "Company") regarding option exercise and issue of new shares. The share capital increase pertaining to the issuance of the new shares has today been registered with the Norwegian Register of Business Enterprises (Nw. Foretaksregisteret). Following such share capital increase, BlueNord's share capital is NOK 14,304,747.58188 consisting of 26,498,640 shares each with a par value of NOK 0.5398295. Following the exercise of options, 0 options remain outstanding

Ellos Group announces intention to initiate change of ownership structure and announces a change to the Board of Directors in the parent company

NOT FOR DISTRIBUTION IN OR TO THE UNITED STATES, CANADA, AUSTRALIA OR JAPAN OR TO ANY U.S. PERSON (AS DEFINED IN REGULATION S OF THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED) OR IN ANY OTHER JURISDICTION WHERE IT IS UNLAWFUL TO PUBLISH OR DISTRIBUTE THIS PRESS RELEASEPress release, Borås, 28 August 2024Ellos Group AB (publ) (the "Parent Company") is working to find a long-term financing solution and today announces its intention to initiate a process for changing the ownership structure of its subsidiary, Ellos Group Nordic AB (publ) ("Ellos Group" or the "Company"). As part of

SALT - School of Applied Technology appoints Damir Sisic as Chief Commercial Officer to strengthen and develop business operations

Stockholm, Sweden – 2024-08-28 – SALT - School of Applied Technology , a pioneer in tech education, is proud to announce the appointment of Damir Sisic as its new Chief Commercial Officer (CCO). This strategic recruitment is a significant step forward as SALT continues to focus on supporting Swedish businesses in building and developing tech competencies through cutting-edge learning and development initiatives. Damir Sisic brings extensive experience from the Learning & Development (L&D) sector, having held key roles at companies like Brights Learning and Voxo, where he

Betmotion Applies for Federal License to Operate in Brazil

Betmotion has initiated its application for a federal license to operate in the regulated Brazilian market—a significant milestone in the brand’s 16-year history. The move reinforces the brand’s commitment to complying with local laws that provide a safe and reliable gaming environment.The ongoing sports betting regulation in Brazil is hugely important, and Betmotion has been involved from the beginning. Being among the first businesses to apply for the license is a clear show of Betmotion’s dedication to transparency and strict adherence to the standards established by Brazilian

Veidekke: Mandatory notification of trade

Mr. Hans Olav Sørlie, Executive Vice President and primary insider in Veidekke ASA, has sold 15 000 Veidekke shares at a price of NOK 125.00 each. After this transaction Mr. Hans Olav Sørlie holds 81 937 shares in Veidekke. For further information, please see enclosure at www.newsweb.no. Ref.: Jørgen Wiese Porsmyr, CFO, +47 907 59 058, jorgen-wiese.porsmyr@veidekke.no This information is subject to disclosure requirements set out in the Market Abuse Regulation EU 596/2014 Article 19 and the Norwegian Securities Trading Act Section 5-12.

Pandox has acquired three aparthotels in central London for MGBP 230

Pandox AB (publ) has completed the acquisition of three aparthotels with a total of 503 rooms in central London. Total transaction value amounts to approximately MGBP 230. Initially, the hotels are expected to contribute approximately MGBP 34 in revenues and approximately MGBP 17 in net operating income, on an annualised basis. The hotels are branded Residence Inn by Marriott and are operated by Axiom Hospitality under a management agreement. The acquisition is financed by available cash funds and a new green bank loan.   “We are happy to have acquired three well-positioned freehold

Cooperation between Wetteri and Astara Finland Oy deepens, Kia and Mitsubishi representation expands to five new locations

Wetteri Plc Press release 28 August 2024 at  11.00Automotive growth company Wetteri's cooperation with Astara Finland, the importer of Kia and Mitsubishi brands, is expanding. With the cooperation, Wetteri’s Kia and Mitsubishi representation will reach five new locations: Rovaniemi, Kemi, Oulu, Ylivieska, and Pori. Aarne Simula, CEO And President, Wetteri Plc: “We are very pleased with deepening the cooperation. We believe that this is an important driver of organic growth, as Kia is one of the most popular car brands in our country. Wetteri operates nationwide, which makes the

Year-end Report (Q4) July 2023 – June 2024

OPENING REMARKS   The fiscal year 2023-2024 has been very productive, eventful and successful for Hamlet Biopharma, addressing the need for new treatment options in patients with cancer or severe bacterial infections. Financing was secured for the continued development of the company’s rich project portfolio. Progress in the cancer therapeutics area is shown by strong clinical data on the tumor response, FDA approval of the company’s IND and Fast Track status for Alpha1H. Significant clinical progress was made in the immuno-therapeutic Phase II studies, reported in patients with the

Shape Robotics held a live Q&A Session, giving updates on the business

Shape Robotics’ CEO held on 27 August 2024 a live Q&A Session giving updates on the business.Disclaimer:The Company has released its interim financial report on 22 August 2024; additional information is available in the said report. As previously communicated to the investors, Shape Robotics has organized a live Q&A session for the investors community in order to offer updates regarding the business operations. This event is part of a series of events to be organized for the investors’ community. During the live session, Mark Abraham, CEO, responded to several questions received from

Kamux Oyj - Managers' Transactions

Kamux Corporation, Managers’ Transactions, 28.8.2024 at 10:30 Kamux Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Callardo Capital Oy Position: Chief Executive Officer (X) Legal person (1): Person Discharging Managerial Responsibilities In Issuer Name: Juha Kalliokoski Position: Member of the Board Issuer: Kamux Oyj LEI: 743700KCVYIYNLPZYN56 Notification type: INITIAL NOTIFICATION Reference number: 75660/5/6 ____________________________________________ Transaction date:

Correction: Everfuel presents second quarter results today at 10:00 CEST

Herning, 28 August 2024 – Reminder of Everfuel A/S second quarter 2024 results presentation today at 10:00 CEST. CEO Jacob Krogsgaard and CFO Jesper Ejlersen will present the company's results at 10:00 CEST and invite investors, analysts, and media to join the live webcast presentation. The presentation is expected to last up to one hour, including Q&A, and can be followed via live webcast. The second quarter presentation is attached and will also be made available on the Everfuel webpage and at www.newsweb.no. Jacob and Jesper will also present the key details from the recommended

Legalbuddy joins Katalysen’s portfolio

On August 13, Katalysen and LegalWorks Group announced a partnership to unlock top-tier law functions for all businesses. As part of that partnership, Katalysen will help co-develop LegalWorks Group venture Legalbuddy. In the process, Katalysen obtains warrants on Legalbuddy shares, and Legalbuddy joins Katalysen’s portfolio of innovative ventures.Legalbuddy was founded with a clear vision: to make law much more accessible to many more people and their businesses.  The legal industry lacks smart technology solutions to help businesses use the law in a cost-effective way—a key factor for

Groundbreaking Study Reveals Enhanced Natural Vitamin B12 Production in Spirulina Through Photonic Management

Reykjavík, Iceland – 2024-08-28 09:15 CET – A new study conducted by an international team of researchers has unveiled a pioneering approach to boosting the production of active vitamin B12 in Spirulina (Arthrospira platensis) using photonic management in scalable photobioreactors. This innovative method could pave the way for Spirulina to become a sustainable and efficient alternative to animal-based sources of vitamin B12, addressing a critical global micronutrient deficiency. The research, published in the journal Discover Food, demonstrates that specific light conditions in

Etteplan releases a profit warning and lowers its guidance for 2024

Etteplan Oyj, Stock Exchange Release/Insider information, August 28, 2024 at 10.15 a.m. EEST Etteplan releases a profit warning and lowers its guidance for 2024 The revenue is expected to be EUR 360-375 million and the operating profit (EBIT) about EUR 24-27 million In its half year financial report published on August 8, 2024, Etteplan estimated its revenue for 2024 to be EUR 375-390 (2023: 360.0) million and the operating profit (EBIT) to be EUR 28-30 (2023: 25.5) million. Etteplan is lowering its previous estimate of 2024 revenue and operating profit (EBIT) due to the weaker-

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 187 – 28 AUGUST 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 171/24 and 173/24, respectively. Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Martin Badsted, Chief Financial Officer, tel.: +45 33 42 05 26, e-mail: mba@norden.com

Sinch Launches Customer Connections Resource Hub in Europe

Features include a free connection assessment tool to provide data-backed recommendations for improving marketing communications across multiple channels STOCKHOLM, Sweden – August 28th, 2024 – Sinch (Sinch AB (publ) – XSTO: SINCH), which is pioneering the way the world communicates through its Customer Communications Cloud, today announced that its new Customer Connections hub, an online resource center designed to support customer experience (CX) professionals and marketers, will now be available in Europe across all digital channels. The hub is designed to support European marketers at

Survey: Environmental awareness among vessel passengers is increasing – more than half of respondents plan to choose climate-smart alternatives

Finnish maritime travellers are increasingly environmentally aware, and for the third straight year Viking Line was named the most sustainable shipping company in ferry service between Finland and Sweden, according to the market researcher EPSI Rating ’s 2024 survey. Viking Line is encouraging its customers to join in the company’s sustainability work, which includes operating its vessels on the Turku route solely using biofuel for one week, starting on Baltic Sea Day.For the third straight year, Finnish maritime travellers have named Viking Line the most sustainable shipping company in

Knox Energy Solutions AS – Notification of Warrant Exercise by Blue Concept Ltd.

(Oslo, 28 August 2024) Knox Energy Solutions AS (the "Company") refers to the Company's stock exchange announcement on 27 August 2024 regarding the allocation of warrants to Blue Concept Ltd. as resolved by the Company's extraordinary general meeting 23 August 2024 (the "EGM"). Blue Concept Ltd. has notified the exercise of warrants pursuant to the EGM resolution. The number of warrants corresponds to the maximum number permissible under the terms set out in the EGM resolution, i.e., 340,844,221 warrants, and within the prescribed deadline. The number of shares issued may be reduced

Inhalation Sciences AB (publ) releases Q2 Report 2024

(Stockholm, Sweden, 28 August 2024) Inhalation Sciences AB announces that its Q2 Report for 2024 is now available on the company’s website.To read the whole report (in Swedish), visit: http://inhalation.se/investors/finansiella-rapporter/ CEO statement Our journey towards achieving the company's strategic goals has continued during the second quarter. We have worked purposefully towards a positive cash flow, which has yielded results in the form of an improved operating profit of 24% by the first half of 2024, compared to the same period the year before. Our pipeline in the form of

Assemblin Caverion Group Interim Financial Information Q2 2024: A successful start to the merger, with improved margins and long-term financing secured

Regulatory disclosure, 28 August 20248:30 CET“The merger of Assemblin Caverion Group has had a strong start at the same time as the underlying performance has continued to improve, enhanced by synergies from the combination.”Mats Johansson, President and CEO Q2 | April–June 2024 (“the quarter”) · Net sales for the quarter decreased by 0.8 percent to SEK 10,884 million (10,975), of which 1.3 percentage points were negative organic growth, and positively impacted by 0.5 percentage points of acquisition-driven and -0.1 percentage points of currency-driven growth. · Adjusted

BPC Instruments reports results for H1 and Q2 2024

BPC Instruments (“BPC” or “the Company”) hereby publishes the half-year report for the period January 1—June 30, 2024. The half-year report is available as an attached file to this release and on the Company’s website . Below is a summary of the report.CEO Dr. Jing Liu comments: "As we return from our summer break, I’m pleased to report steady growth and strategic progress for BPC Instruments in the first half of 2024. In Q2, we achieved net sales of 14,074 kSEK and an EBIT of 3,240 kSEK. Our active participation in key global events has

Wetteri Plc’s half-year report 1 January to 30 June 2024: Revenue grew by 42%, measures to improve profitability in progress

Wetteri Plc  Half-year Report 28 August 2024 at 9.30Summary of the review period 1 April to 30 June 2024 · The Group’s revenue was EUR 131,1 million ((comparison period: EUR 106,8 million in April-June 2023) with an increase of 23% · Adjusted EBITDA vas EUR 4,6 million (EUR 5,2 million) · The adjusted operating profit was EUR 0,7 million (EUR 2,2 million) · The operating profit was EUR -0,7 million (EUR 1,3 million) · The revenue of the Passenger Cars segment increased by EUR 17,4 million (25 %) year-on-year · The revenue of the Heavy Equipment segment increased by EUR 2,

BioStock: New CFO at Neola Medical

Neola Medical has strengthened its management team, adding David Folkesson as the new CFO. He joins at an important stage for the company, which is currently preparing for clinical validation of Neola. BioStock has contacted David to find out more about his background and how he sees the journey that currently lies ahead.Read the full article at biostock.se : https://www.biostock.se/en/2024/08/new-cfo-at-neola-medical/ This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se

There are no items matching the current filter
There are no more items matching the current filter
Back to top